Single answer
Is Novavax Inc (NVAX) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $0.94 or -6.14%
(In 13 weeks 15 hours 49 minutes and 15 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Novavax Inc is $14.50, which is $6.13 (73.24%) above the current price today's price.
Low target: $11.00 | High target: $18.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Novavax Inc a biotechnology company focuses on the discovery development and commercialization of vaccines to prevent serious infectious diseases and address health needs The companys vaccine candidates include NVXCoV2373 a coronavirus vaccine candidate that is in two Phase III trials one Phase IIb trial and one Phase III trial NanoFlu a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial and ResVax a respiratory syncytial virus RSV fusion F protein nanoparticle vaccine candidate It is also developing RSV F vaccine that is in Phase II clinical trial for older adults 60 years and older as well as that is in Phase I clinical trial for pediatrics It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development manufacturing and commercialization of NVXCoV2373 a COVID19 vaccine candidate Novavax Inc was incorporated in 1987 and is headquartered in Gaithersburg Maryland
Website: https://www.novavax.com
Rates and inflation backdrop
US inflation for December 2025 was 0.31%. Over the last 12 months, inflation is 3.03%. The 10-year yield is 4.29 and is up 0.240 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.21. Cash flow to debt ratio: -1.51. Net profit margin: 32.10%. Inflation risk score: low (0.45/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Novavax Inc is $36.5M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Novavax Inc, 2016-02-04 had a stock price of $97.60. If you invested back then, your return now would be a loss of $89.23 per share or 91.42%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.